ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,750,000 | -2.3% | 5,000,000 | 0.0% | 0.05% | -7.4% |
Q3 2022 | $2,816,000 | +1.7% | 5,000,000 | 0.0% | 0.05% | -28.9% |
Q2 2022 | $2,769,000 | +7.4% | 5,000,000 | +99900.0% | 0.08% | +10.1% |
Q1 2022 | $2,578,000 | -2.3% | 5,000 | 0.0% | 0.07% | -15.9% |
Q4 2021 | $2,638,000 | – | 5,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PenderFund Capital Management Ltd. | 29,679,000 | $23,720,000 | 7.42% |
SILVERBACK ASSET MANAGEMENT LLC | 11,750,000 | $6,487,175 | 0.92% |
DCF Advisers, LLC | 1,550,000 | $884,000 | 0.57% |
Context Capital Management, LLC | 14,764 | $8,274,000 | 0.56% |
AGF Investments LLC | 7,000,000 | $3,872,000 | 0.36% |
WHITEBOX ADVISORS LLC | 19,600,000 | $10,682,000 | 0.30% |
Pentwater Capital Management LP | 46,411,000 | $26,134,000 | 0.29% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $11,591,000 | 0.27% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 24,000,000 | $13,275,000 | 0.24% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 14,900,000 | $8,493,000 | 0.12% |